Uromitexan Infusion is a commercial drug that is prescribed in the form of Infusion. It is typically used for the treatment of Hemorrhagic Cystitis.
The right dosage of Uromitexan Infusion depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Uromitexan Infusion include Lightheadedness. Besides the aforementioned side effects, there are other adverse effects of Uromitexan Infusion as well, which are listed below. Normally, these side effects of Uromitexan Infusion are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Uromitexan Infusion has a Safe effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Uromitexan Infusion related warnings talks about Uromitexan Infusion's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Uromitexan Infusion contraindications section.
Additionally, Uromitexan Infusion may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Uromitexan Infusion, it is important to know that it is not safe while driving, and is not habit-forming.
Uromitexan Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Uromitexan Infusion is used -
Moderate
Mild
Common
Is the use of Uromitexan Infusion safe for pregnant women?
Pregnant women can take Uromitexan safely.
Is the use of Uromitexan Infusion safe during breastfeeding?
Breastfeeding women may feel side effects of Uromitexan. If you see any side effects, stop taking Uromitexan immediately and talk to your doctor. Take Uromitexan again, only after your doctor's advice.
What is the effect of Uromitexan Infusion on the Kidneys?
There are no side effects of Uromitexan on the kidneys.
What is the effect of Uromitexan Infusion on the Liver?
Using Uromitexan does not have any harmful effects on the liver.
What is the effect of Uromitexan Infusion on the Heart?
Uromitexan is not harmful for the heart.
Uromitexan Infusion should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Uromitexan Infusion unless your doctor advises you to do so -
Is this Uromitexan Infusion habit forming or addictive?
No, there is no any evidence that Uromitexan Infusion is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Uromitexan Infusion you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Uromitexan Infusion only as per medical advice.
Is it able to treat mental disorders?
No, the use of Uromitexan Infusion in mental disorders is not effective.
Interaction between Food and Uromitexan Infusion
Due to a lack of research, nothing can be said about the consequences of taking Uromitexan Infusion together with food.
Interaction between Alcohol and Uromitexan Infusion
It is difficult to say anything about the effect of Uromitexan Infusion and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mesnex (mesna)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860, 876
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 822-824
